Do you need to accelerate antigen identification, simplify preparation, boost production, or integrate multi-modal R&D data for insight generation? Do you handle subunit, recombinant, mRNA, DNA, viral vector, and other innovative vaccine technologies and need to improve traceability or implement automation?
This is where Genedata comes in.
Our Customers
- Antigen Preparation. Simplified.
- Research Efficiency. Amplified.
- Quality by Design. Systematic Development.
- Integrative Analysis. Unlock Insights
Antigen Preparation. Simplified.
- Register and characterize antigens for extraction from lab-cultivated organisms, expression from engineered vectors, or immune response analysis.
- Identify relevant epitopes with less effort and more accuracy, using practical visualizations and analytical tools.
- Express, purify, formulate, and test antigens efficiently and traceably to ensure quality, consistency, and rapid scalability.
Research Efficiency. Amplified.
- Automate and scale up cloning, screening, engineering, expression, and purification of mono/multivalent vaccine candidates and their components.
- Resolve bottlenecks such as data integration, standardization, and manual data entry to accelerate your vaccine R&D.
- Integrate all lab instruments and robotic devices to facilitate seamless automated data transfer, particularly during the pivotal stages of vaccine candidate screening and formulation analysis.
- Leverage structured data and modeling tools to earlier identify potential developability risks.
Quality by Design. Systematic Development.
- Streamline the entire bioprocess development workflow for all vaccine types including synthetic and cell-free approaches.
- Implement process analytical technology (PAT) to monitor vaccine production and ensure vaccine quality.
- Integrate and centralize analytics data from every step in a single source of truth with real-time access to all vaccine project information.
- Generate a full historical record for each vaccine batch with a single mouse click, ensuring complete traceability, from raw materials to final products, including all aliquots and analytical samples.
Integrative Analysis. Unlock Insights
- Seamlessly combine diverse data from different vaccine development stages.
- Drive integrative analyses using tailored analytical solutions for every user.
- Be GxP-validation ready with a single source of truth and comply out-of-the-box with regulatory standards.
- Access all vaccine R&D data easily in an intuitive, user-friendly interface.
- Leverage data from antigens, protein subunits, viruses, nucleic acids, as well as multi-omics and clinical and real-world data to drive vaccine development using efficient primary and secondary data analysis.
Glycopeptide Characterization of SARS-CoV-2 Vaccines
Discover how Sanofi researchers used glycopeptide libraries to expedite the characterization of N-glycosylation patterns in Sf9-derived SARS-CoV-2 spike proteins, revealing consistent glycosylation across batches and manufacturers, enhancing vaccine development efficiency.
Digitalization Fuels Innovation in Vaccine Process Development
Discover how digitalization fuels innovation in vaccine process development, reducing costs and time to market, while ensuring maximum automation, data integrity, and scalability across all vaccine formats with Genedata.
Comprehensive Biosafety for Viral Vector Vaccine Development
Discover how Genedata streamlines biosafety testing for viral vector vaccines, ensuring product integrity by automating data analysis and decision-making, and detecting problematic mutations with customizable metrics and automated reporting.